HomeStock ScreenerEverest OrganicsQuarterly Results

Everest Organics Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹-1 Cr
QMarch 2025
Quarterly Results

In 2026, Everest Organics (EVERESTO) reported revenue ₹190 Cr and net profit ₹6 Cr. For annual financials, live price and key ratios, visit EVERESTO share price.

EVERESTO Quarterly Results — Revenue, Profit & EPS Highlights

Everest Organics latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Also explore EVERESTO share price history to track price trends across different timeframes.

  • Revenue of ₹160 Cr in March 2025 (+0.0% vs March 2025, -19.2% vs March 2024)
  • Net Profit of ₹-1 Cr in March 2025 (+0.0% vs March 2025)
  • EBITDA of ₹8 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 5.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹-2.97 in March 2025 (+0.0% vs March 2025)

Everest Organics Quarterly Results — Revenue, EBITDA, Net Profit & EPS

EVERESTO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 190 160 198 190 202 18.8% -
Net Profit (₹ Cr) 6 -1 0 0 1 - -
EBITDA (₹ Cr) 18 8 12 8 9 - -
EPS (₹) 6.00 -2.97 0.17 -0.23 1.43 - -
Operating Margin (%) 9.0% 5.0% 6.0% 1.0% 3.0% - -

EVERESTO Share Price Trend — 1-Year Movement Across Quarterly Results

Everest Organics 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Compare with EVERESTO stock valuation models to assess whether the stock is under or overvalued.

Profitability Ratios

Profit Margin -0.6%
EBITDA Margin 5.0%
Operating Margin 5.0%
ROE (Annual) -1.4%

Balance Sheet Highlights

Total Assets ₹225 Cr
Total Equity ₹70 Cr
Current Assets ₹148 Cr
Current Liabilities ₹15 Cr

Cash Flow Analysis

Operating Cash Flow ₹-5 Cr
Investing Cash Flow ₹-5 Cr
Financing Cash Flow ₹16 Cr
Net Cash Flow ₹6 Cr

Current Market Data

Current Price ₹255.70
Exchange BSE
Last Updated May 13, 2026

EVERESTO vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Everest Organics latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹443,373.10 Cr 1824.8 14,875 3,125 +10.8% - 21.0% 140.4
Divis Laboratories
Sept 2025
₹178,235.60 Cr 6796.0 2,860 689 +7.1% - 24.1% 261.7
Torrent Pharmaceuti…
Sept 2025
₹145,389.39 Cr 4295.8 3,219 591 +11.3% - 18.4% 244.9
Cipla
Mar 2026
₹107,240.96 Cr 1327.6 6,612 543 -14.3% -4.0% 8.2% 193.2
Dr Reddys Laborator…
Mar 2026
₹105,607.38 Cr 1265.3 7,996 221 -12.5% -11.5% 2.8% 477.5
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores